[Application of human-derived samples in preclinical research]

Area of Science:

• Biomedical Research
• Drug Discovery and Development
• Stem Cell Biology

Background:

• Drug discovery is lengthy, costly, and has a low success rate.
• Predicting clinical effects early and stratifying patients improves success rates.
• Non-clinical research using human-derived samples is increasingly vital.

Purpose of the Study:

• To describe the use of human-derived samples in non-clinical research.
• To highlight the utility of induced pluripotent stem cells (iPSCs) in drug discovery.
• To discuss the advantages and limitations of human-derived samples.

Main Methods:

• Utilizing human-derived samples, including patient-derived samples.
• Focusing on the application of induced pluripotent stem cells (iPSCs).
• Reviewing ethical procedures and considerations for sample usage.

Main Results:

• Human-derived samples offer unique human-specific characteristics absent in animal models.
• Patient-derived samples aid in understanding pathogenesis, disease modeling, and predicting clinical effects.
• iPSCs are valuable for diseases difficult to model in animals.

Conclusions:

• Human-derived samples, particularly iPSCs, are essential for advancing drug discovery.
• Patient-derived samples provide critical insights into disease mechanisms and treatment efficacy.
• Responsible use of human-derived samples, with ethical oversight, is paramount for future research.